HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)

NCT01576341 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
417
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sandoz